Title: Ospemifene metabolism in humans in vitro and in vivo: metabolite identification, quantitation, and CYP assignment of major hydroxylations.
Journal: Drug metabolism and drug interactions 20130101
Title: An update on selective estrogen receptor modulators for the prevention and treatment of osteoporosis.
Journal: Maturitas 20120301
Title: Ospemifene and 4-hydroxyospemifene effectively prevent and treat breast cancer in the MTag.Tg transgenic mouse model.
Journal: Menopause (New York, N.Y.) 20120101
Title: Liver X receptors as regulators of macrophage inflammatory and metabolic pathways.
Journal: Biochimica et biophysica acta 20110801
Title: Pharmacologic evaluation of ospemifene.
Journal: Expert opinion on drug metabolism & toxicology 20100601
Title: An innovative method to classify SERMs based on the dynamics of estrogen receptor transcriptional activity in living animals.
Journal: Molecular endocrinology (Baltimore, Md.) 20100401
Title: Selective estrogen receptor modulators decrease the production of interleukin-6 and interferon-gamma-inducible protein-10 by astrocytes exposed to inflammatory challenge in vitro.
Journal: Glia 20100101
Title: Ospemifene effectively treats vulvovaginal atrophy in postmenopausal women: results from a pivotal phase 3 study.
Journal: Menopause (New York, N.Y.) 20100101
Title: Endometrial safety: a key hurdle for selective estrogen receptor modulators in development.
Journal: Menopause (New York, N.Y.) 20100101
Title: Current and emerging pharmacologic therapies for the management of postmenopausal osteoporosis.
Journal: Journal of women's health (2002) 20091001
Title: Ospemifene use in postmenopausal women.
Journal: Expert opinion on investigational drugs 20090601
Title: Estrogen and the selective estrogen receptor modulator (SERM) protection against cell death in estrogen receptor alpha and beta expressing U2OS cells.
Journal: Molecular and cellular endocrinology 20080716
Title: Pharmacologic effects of ospemifene in rhesus macaques: a pilot study.
Journal: Basic & clinical pharmacology & toxicology 20080601
Title: Differential effects of selective oestrogen receptor modulators (SERMs) tamoxifen, ospemifene and raloxifene on human osteoclasts in vitro.
Journal: British journal of pharmacology 20070601
Title: The cardiovascular effects of selective estrogen receptor modulators.
Journal: Annals of the New York Academy of Sciences 20061201
Title: Effects of ospemifene and raloxifene on biochemical markers of bone turnover in postmenopausal women.
Journal: Journal of bone and mineral metabolism 20060101
Title: Ineffectiveness of American ginseng in the prevention of dimethylbenzanthracene-induced mammary tumors in mice.
Journal: Oncology research 20060101
Title: Ospemifene inhibits the growth of dimethylbenzanthracene-induced mammary tumors in Sencar mice.
Journal: The Journal of steroid biochemistry and molecular biology 20051101
Title: Effects of ospemifene and raloxifene on hormonal status, lipids, genital tract, and tolerability in postmenopausal women.
Journal: Menopause (New York, N.Y.) 20050301
Title: Selective estrogen receptor modulators inhibit growth and progression of premalignant lesions in a mouse model of ductal carcinoma in situ.
Journal: Breast cancer research : BCR 20050101
Title: Selective estrogen receptor modulators prevent neointima formation after vascular injury.
Journal: Molecular and cellular endocrinology 20041130
Title: Ospemifene Hormos.
Journal: Current opinion in investigational drugs (London, England : 2000) 20040401
Title: Effects of ospemifene, a novel SERM, on biochemical markers of bone turnover in healthy postmenopausal women.
Journal: Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20040301
Title: Comparative study of the short-term effects of a novel selective estrogen receptor modulator, ospemifene, and raloxifene and tamoxifen on rat uterus.
Journal: The Journal of steroid biochemistry and molecular biology 20040201
Title: Effects of ospemifene, a novel SERM, on hormones, genital tract, climacteric symptoms, and quality of life in postmenopausal women: a double-blind, randomized trial.
Journal: Menopause (New York, N.Y.) 20030101
Title: Effects of ospemifene, a novel SERM, on vascular markers and function in healthy, postmenopausal women.
Journal: Menopause (New York, N.Y.) 20030101
Title: Effects of ospemifene (FC-1271a) on uterine endometrium, vaginal maturation index, and hormonal status in healthy postmenopausal women.
Journal: Maturitas 20021120
Title: In vitro and in vivo biologic effects of Ospemifene (FC-1271a) in breast cancer.
Journal: The Journal of steroid biochemistry and molecular biology 20010601
Title: Cone voltage and collision cell collision-induced dissociation study of triphenylethylenes of pharmaceutical interest.
Journal: Rapid communications in mass spectrometry : RCM 20010101
Title: Unkila M, et, al. Vaginal effects of ospemifene in the ovariectomized rat preclinical model of menopause. J Steroid Biochem Mol Biol. 2013 Nov;138:107-15.
Title: Bruyniks N, et, al. Systematic indirect comparison of ospemifene versus local estrogens for vulvar and vaginal atrophy. Climacteric. 2017 Jun; 20(3): 195-204.
Title: Qiang Qv.et al.Selective estrogenic effects of a novel triphenylethylene compound, FC1271a, on bone, cholesterol level, and reproductive tissues in intact and ovariectomized rats. Endocrinology.Feb;141(2):809-20. 25. (2000).
Title: Tracy L. Taras et al.In vitro and in vivo biologic effects of Ospemifene (FC-1271a) in breast cancer. The Journal of Steroid Biochemistry and Molecular Biology 77(4-5):271-9,(2001).
